From: The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women
Quartile of FEV1 | 1 | 2 | 3 | 4 | Trend Test (p value)†|
---|---|---|---|---|---|
Range of FEV1 (% predicted) | 89 to 120 | 78 to 89 | 64 to 78 | 27 to 64 | Â |
Number of Subjects | 97 | 97 | 97 | 97 | Â |
Unadjusted Odds for Adenocarcinoma | 1 (reference) | 0.88 (0.50–1.55) | 0.55 (0.31–1.00) | 0.48 (0.27–0.86) | 0.004 |
Adjusted Odds for Adenocarcinoma* | 1 (reference) | 0.78 (0.43–1.44) | 0.59 (0.32–1.09) | 0.52 (0.28–0.98) | 0.028 |
Unadjusted Odds for Squamous Cell Carcinoma | 1 (reference) | 1.28 (0.73–2.25) | 1.79 (1.01–3.17) | 2.35 (1.31–4.20) | <0.001 |
Adjusted Odds for Squamous Cell Carcinoma* | 1 (reference) | 1.43 (0.78–2.63) | 1.65 (0.90–3.03) | 2.09 (1.12–3.90) | 0.019 |